Leavell Investment Management, Inc. Biogen Inc. Transaction History

Leavell Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	SELL	$282.99 - $369.05 $226,392 - $295,240	-800 Closed	0 $0
Q1 2021 Apr 15, 2021	BUY	$242.95 - $284.63 $194,360 - $227,704	800 New	800 $224,000
Q4 2020 Jan 26, 2021	SELL	$236.26 - $355.63 $189,008 - $284,504	-800 Closed	0 $0
Q4 2019 Jan 22, 2020	SELL	$220.06 - $304.07 $88,024 - $121,628	-400 Reduced 33.33%	800 $237,000
Q3 2019 Oct 28, 2019	SELL	$217.44 - $243.88 $43,488 - $48,776	-200 Reduced 14.29%	1,200 $279,000
Q2 2019 Jul 18, 2019	BUY	$219.29 - $241.72 $109,645 - $120,860	500 Added 55.56%	1,400 $327,000
Q4 2018 Jan 24, 2019	BUY	$278.5 - $352.75 $250,650 - $317,475	900 New	900 $271,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Leavell Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Leavell Investment Management, Inc. with notifications on news.